Background: Laparoscopic colectomy has been shown to have equivalent oncologic outcomes to open colectomy for the management of colon cancer, but its adoption nationally has been slow. This study investigates the prevalence and factors associated with laparoscopic colorectal resection at National Comprehensive Cancer Network (NCCN) centers.
Methods
The study cohort consisted of patients with stage I-IV colon or rectal cancer, diagnosed between September 1, 2005 and December 31, 2010, who received primary surgical care at one of eight institutions participating in the NCCN Colorectal Cancer Outcomes Project. These institutions were selected for participation in the colorectal database project, based on participation in prior database collection efforts. They include the two largest specialty cancer centers in the United States, are geographically diverse, and represent the composition of patients seen at all 21 NCCN institutions. Patients were excluded from the study if their primary operation was a Hartmann's procedure, total or partial pelvic exenteration, exploratory laparoscopy, appendectomy, proctectomy, or transanal excision. Additional exclusion criteria included incomplete information, synchronous colon and rectal cancer, or incomplete staging data.
The data collection process, data transmission methods, and data storage protocols were approved by the participating institutions' respective Institutional Review Boards. Rigorous data quality assurance processes were in place, as described in prior studies (16) (17) (18) .
Data Variables
Data from patients' medical records for the NCCN Outcomes Project were collected longitudinally from diagnosis, based on chart review. At baseline-corresponding to each patient's date of presentation to the institution-information on socioeconomic status, insurance coverage, comorbidity, and physician-reported Eastern Cooperative Oncology Group (ECOG) performance status were abstracted. Comorbidity at presentation was assigned using the Charlson Index, based on chart review. The zip code of each patient's residence is collected at first visit to an NCCN institution; this was used to estimate median household income by linking it to the 2000 Census data. Patients' medical records are systematically reviewed at four, eight, and 12 months after presentation, and annually thereafter, to capture treatment and recurrence data. Starting at four months from baseline, data on preoperative clinical and pathologic TNM staging based on the American Joint Committee on Cancer Staging Manual (6th edition for patients presenting before January 1, 2010; 7 th edition for patients presenting on or after January 1, 2010), all surgical treatment, neoadjuvant and/or adjuvant chemotherapy or radiation are abstracted into a database by NCCN-trained Clinical Research Assistants at each institution. Rigorous data quality assurance processes are maintained for the NCCN Outcomes Database Project. This includes initial and follow-up data management training for study personnel, programmed logic checks against the pooled data repository, routine quality assurance reports to each institution for rectification by the data managers, and on-site audits of a random sample of source documents against the submitted data, within the first few months of data collection (repeated annually). Each NCCN institution is audited for data completeness at routine intervals.
Statistical Analysis
The primary endpoint was MIS vs open surgery. The association between MIS and patient demographic and clinical features was characterized using descriptive statistics for two cohorts (colon cancer, rectal cancer). The median and range were reported for continuous variables, and the number and proportion of patients for categorical variables. A Chi-square test for association was used to compare proportions between MIS and open surgery groups. For median age and body mass index comparisons, a Wilcoxon rank-sum test was used.
To examine time trends of MIS and variation among institutions in adopting MIS, the number and proportion of patients undergoing MIS vs open surgery was stratified by diagnosis year and NCCN institution. A bar graph by diagnosis year was used to depict MIS time trends separately for colon and rectal cancer.
The association between MIS in colon cancer and each variable was assessed independently in a univariate logistic regression model. Parameters found to be potentially associated with MIS, based on a P value of less than or equal to .20, were included in the initial multivariable model. The final multivariable model included predictors with twosided P less than .05, and control variables defined a priori (NCCN institution, Charlson comorbidity score, sex). Point estimates of the multivariable model were reported as odds ratios (ORs) and 95% confidence intervals (CIs) with the two-sided P value for each odds ratio. Because the same data were used for model selection and evaluation, the P values may be smaller than actually the case.
And because seven variables were included in the final model, to adjust for multiple comparisons, the Bonferroni cutpoint for statistical significance is 0.05/7 = 0.007. All statistical analyses were conducted using SAS software (SAS 9.3 Cary, NC, USA).
Results

Study Characteristics
Characteristics of the study cohort are shown in Table 1 28 (+/-6). The majority had an ECOG score of 0, 80% (1237/1539), and a Charlson score of 0, 76% (1170/1539). Nearly all had low anterior resections (97%, n = 1489). Final pathologic stage was most often 0/I (36%, n = 550).
Comparing MIS with open colectomy for colon cancer across all stages, 899 patients (36%) underwent MIS; 1594 (64%) had an open procedure. MIS patients were more likely to have a Charlson score of 0 (68% vs 64%, P = .04), household income greater than or equal to $80 000 (11% vs 8%, P < .001); the majority were older (age 64.0 vs Rates of MIS at individual centers ranged from 15% to 86% of patients across the time period; in the last two years, rates among institutions varied from 23% to 79%. While rates varied at individual institutions, there was an increase overall in percent MIS at NCCN centers.
Multivariable Analysis
On multivariable analysis (Table 2) , factors associated with minimally invasive colectomy for stage I-IV colon cancer patients undergoing surgery at an NCCN institution were older age (P = .02), male sex (P = .006), fewer comorbidities (P ≤ .001), lower final T-stage (P < .001), median household income greater than $80 000 (P < .001), ECOG performance status of 0 (P = .02), and NCCN institution (P < .001). The following factors were tested in the univariate logistic regression: age at diagnosis, sex, race/ ethnicity, median household income, insurance, BMI (<25, 25-30, 30+), ECOG performance status, Charlson comorbidity score, pathologic TNM stage, number of lymph nodes positive, neoadjuvant therapy, and NCCN institution. Only race/ethnicity (P = .72 univariate), and BMI (P = .30 univariate) were not considered in the multivariable model. The final model has the following factors: age at diagnosis, sex, median household income, ECOG performance status, Charlson comorbidity score, pathologic TNM stage, neoadjuvant therapy, and center. Number of lymph nodes positive (P = .99 saturated multivariable model) and insurance (P = .09 saturated multivariable model) were excluded from the multivariable model, since the two-sided P value was not less than .05. Even after controlling for other parameters, NCCN institution was a statistically significant predictor of MIS. The institution-specific rates of MIS ranged from 23% to 75%. Patients undergoing surgery at institutions 1 (Adjusted OR = 6.02, 95% CI = 3.95 to 9.2), 3 (Adjusted OR = 1.95, 95% CI = 1.37 to 2.78), or 7 (Adjusted OR = 1.94, 95% CI = 1.44 to 2.62) were statistically significantly more likely to undergo minimally invasive CRC surgery than patients at institution 8 (referent group). 
Discussion
Over the last decade, numerous clinical trials and cohort studies have validated the use of MIS colectomy for patients with CRC. This study shows that the rates of laparoscopic colectomy in both colon and rectal cancer from September 1, 2005 to December 31, 2010 at the eight NCCN institutions participating in the Colorectal Outcomes Database Project has increased since the COST trial and is higher than rates reported from many US population-based series.
Over the past 15 years, randomized trials have demonstrated at least equivalent 30-day outcomes among patients undergoing laparoscopic colectomy for colon cancer (19) . More recently, the COLOR, CLASSIC, and COST trials have confirmed the results of previous studies, showing at least equivalent long-term outcomes and multiple short-term benefits for laparoscopic colectomy (6, 7, 20) .
While evidence supports MIS, rates on its use have varied. (23, 24) published reviews of the NIS data, showing trends nearing 50% nationally (11) . This is the first evidence that laparoscopic colectomy for cancer has become more mainstream (24, 25) . However, these studies, utilizing administrative databases, can only identify limited factors associated with MIS.
Interestingly, most groups noted substantial variation regionally and across center type (22, 24, 25) . The fact that academic centers have led the way is not surprising, given that the majority of trials examining MIS have been performed at academic centers (9, 26) . More interesting is the regional variation, with higher rates reported in the US Northeast and South (24, 25) . We found statistically significant variability across institutions, even after accounting for stage and comorbidities. Patients are more likely to have MIS at certain centers than at others.
Variation in use of MIS among NCCN institutions is intriguing. All employ highly trained, specialized surgeons. The lag may be related, as many surgeons require retraining in laparoscopic techniques. Retraining of surgeons is costly and time consuming. The impetus for doing so includes clinicians' desire to improve patient outcomes by way of the smaller incisions and quicker recovery associated with MIS. Patients undoubtedly play a role, and may demand MIS or seek out surgeons who offer it. Additionally, there may be a delay, as departments must invest in laparoscopic equipment in order to support an MIS program.
The lag in use of MIS in the community may also be because of the associated learning curve. The technical demands of laparoscopic colectomy are greater than in many more commonly performed laparoscopic procedures. Past literature suggests that the learning curve for laparoscopic colectomy ranges from 25 to 60 cases-more than most general surgeons perform in an entire year. At specialized centers, however, surgeons are trained to perform these procedures (27, 28) .
Our cohort, much like those in other nonrandomized studies, shows that MIS patients present with fewer comorbidities have higher incomes and have private medical insurance. This is likely related to the socioeconomic privilege associated with access to NCCN centers. Numerous studies have shown that patients with lower socioeconomic status are less likely to be treated at specialized centers (29, 30) . However, the differences demonstrated in our study are smaller than those in previous reports; in fact, the clinical differences are smaller than previously reported. This suggests that, as physicians become more comfortable with MIS, they may be expanding its use.
While we have do not have specific data looking at why older age would more likely be associated with MIS in our colectomy cohort, it is consistent with several published studies that show that the elderly may benefit the most from MIS (31, 32) . As MIS for colectomy has gained wider usage and more people are trained in MIS, physicians have noted the benefits of MIS, particularly for this older age group, and so it makes sense that its use is increasing. For rectal cancer, where the indications are not well defined, physicians are more likely to be cautious with their patient selection.
While the benefits of MIS are less clear in rectal cancer, recent retrospective studies have shown that total mesenteric excision can be safely performed using MIS, with no statistically significant differences in survival compared with an open approach (12, 13) . Data from the COLOR II trial demonstrate that carefully selected patients treated by skilled surgeons have similar short-term safety and oncologic outcomes, with shorter recovery. Long-term outcomes have not been established (14) . Intraoperative conversion from laparoscopy to open surgery is markedly higher in rectal cancer, reflecting a greater level of procedural complexity (33) (34) (35) . Studies show a higher learning curve for laparoscopic rectal resections, which likely explains why their use is greater at specialized high-volume centers (36) . Although robotic techniques appear to facilitate rectal resection, optimal MIS for rectal cancer has yet to be determined (37, 38) .
Although several studies compare MIS with open colectomy-and there is a sense that its use is increasing-no study has specifically examined utilization of laparoscopy for CRC at specialized cancer centers. Furthermore, no study accounts for changes that have occurred since publication of the COST trial and other trials supporting MIS for CRC. Our study shows that these centers have increased use of MIS for CRC to over 50%.
We found that stage IV CRC patients were less likely to undergo MIS. There are several reasons for this. First, a comparatively larger proportion of NCCN patients have pathologic stage IV disease (1, 39) . Second, our analysis was based on final pathologic stage; perhaps these patients had more locally advanced tumors and, as a result, were deemed technically more challenging for laparscopic surgery. Such patients are more likely to have additional disease and may require combined resections. Because of their greater complexity, combined resections are less likely to be done using minimally invasive techniques. We observed that the number of MIS cases is higher in stage I-III patients alone than it is when stage IV patients are factored in. Stage IV CRC is really a different disease process, and other factors must be taken into consideration when treating these patients. Nevertheless, some stage IV cases can be managed using MIS, and these patients may benefit from it most.
The results of this study must be analyzed within the context of the limitations associated with any retrospective study using a large database. Surgeon choice regarding patient management shows a selection bias. To account for this, we made multivariable adjustments for comorbidities, age, and patient factors. But other factors not available in the database are clearly unaccounted for. Additionally, there are limitations in the measures of disease severity. Our multivariable analysis accounts for patient comorbidities using the Charlson Comorbidity Index and ECOG status, but these measures are only surrogates. Finally, as these data come from the nation's leading cancer centerswhich have highly specialized surgeons and disease-specific teams-the outcomes may not be comparable with those found in the general population. Physicians at cancer specialty centers may care for patients who present with more complex and reoperative cases; thus, the number of cases amenable to MIS may be lower than in the general population. Our goal was to examine trends at these specialized institutions, to ascertain whether they are on par with or greater than those found at the national level.
Use of MIS has increased nationally, and this trend is being seen at NCCN centers. Since publication of the COST trial results, nearly one half of all cases are now done laparoscopically. The rate of increase may have lagged because of regional variability, surgeon experience, a higher learning curve, or the fact that many colectomies continue to be done by general surgeons rather than specialists who are fellowship-trained in colon and rectal cancer. We expect that rates will continue to rise as MIS training disseminates and the technology advances.
As more centers offer MIS, its use in the general population will increase. While specialized centers increasingly utilize MIS, there remains a large variability between different centers. This is likely attributable to complexity and case mix, as well as surgeon skill and experience. Because most surgical training programs offer laparoscopy training and there are MIS requirements in surgical training (eg, Fundamentals of Laparoscopic Surgery), younger surgeons completing this training will more likely incorporate MIS into their practice.
Stage IV patients are less likely to be managed with MIS; however, these are the patients who may benefit from it most. MIS is strongly associated with less short-term morbidity and the potential to begin adjuvant therapy sooner. As techniques improve, combined procedures may become more feasible, increasing the number of stage IV patients who are MIS candidates. As surgeons gain technical proficiency, use of MIS is likely to increase-even in this higher-risk population.
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